The article discusses recent amendments to clinical trial regulations in India, emphasizing patient-centric growth and industry optimism ahead of Budget 2026.

Labour-intensive sectors are expected to gain the most, including textiles and apparel, gems and jewellery, leather products, ...

India-US interim trade deal lifts Dalal Street sentiment, boosts export stocks, improves tariff clarity, attracts FII inflows, and positions Nifty Sensex for near-term gains across pharma and textiles ...

US President Donald Trump claims to have pressured French President Emmanuel Macron to raise drug prices in France, arguing that Americans are overpaying while other countries undercharge. The ...

The Greek pharmaceutical industry is poised for growth as international trends reshape the sector. Over the past decade, the ...

The government has lauded Ernest Chemists Limited, a leading pharmaceutical company in Ghana, for 40 years of outstanding ...

AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.

FDA will take “decisive steps” to thwart companies from mass marketing unapproved, compounded versions of GLP-1 drugs ...

The TrumpRx.gov website helps uninsured & cash-paying patients save on 40+ brand drugs. Here's the complete list of ...

After years of conversation, legislators pushed key reforms to pharmacy benefit managers over the finish line, much to the chagrin of the industry. | After years of conversation, legislators pushed ...

Hims & Hers' gambit to sell a $49 compounded version of Novo Nordisk's Wegovy pill is rattling obesity shares, sparking ...

At Web Summit Qatar, AI-powered biotech startups describe how automation, data, and gene editing are filling labor gaps in ...